aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology
February 27, 2020 08:00 ET
|
aTyr Pharma, Inc.
Paper highlights the essential role that histidyl tRNA synthetase (HARS) plays in immune responses in a broad range of inflammatory disease states Lead therapeutic candidate, ATYR1923, being...
aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering
February 06, 2020 09:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Feb. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Announces Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of ATYR1923 in Japan
January 06, 2020 08:00 ET
|
aTyr Pharma, Inc.
aTyr eligible to receive up to $175 million in total payments, including $8 million upfront, plus tiered sales royalties Kyorin to fund all ATYR1923 development and commercialization activities in...
aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923
December 12, 2019 08:00 ET
|
aTyr Pharma, Inc.
ATYR1923 safe and well tolerated in initial 15 randomized patients with pulmonary sarcoidosis No drug-related serious adverse events observed SAN DIEGO, Dec. 12, 2019 (GLOBE NEWSWIRE) -- aTyr...
aTyr Pharma Announces Third Quarter 2019 Results and Provides Corporate Update
November 14, 2019 16:01 ET
|
aTyr Pharma, Inc.
Interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients due in December 2019 Company to host conference call and webcast today, November 14, at...
aTyr Pharma to Present at the Stifel Healthcare Conference 2019
November 13, 2019 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma to Announce Third Quarter Results on November 14th
November 07, 2019 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Announces Research Collaboration with Boston Children’s Hospital
October 22, 2019 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma to Participate in September Conferences
September 18, 2019 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
aTyr Pharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 04, 2019 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...